Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Phosphatase has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Each alkaline phosphatase active site holds two zinc ions that are directly required for hydrolysis of the phosphate ester. Without them the enzyme has no catalytic activity. This is why serum alkaline phosphatase activity falls when zinc status is poor, and it is a well characterised metalloenzyme relationship. Note the enzyme activity is a marker of zinc status, not a health outcome by itself.
Beyond the two zinc ions, alkaline phosphatase carries a magnesium site that stabilises the active conformation. Assays for the enzyme deliberately include magnesium for this reason. It is a settled cofactor relationship from enzymology. It does not follow that supplementing magnesium raises anyone's enzyme activity above normal.
Phosphorylated B6 cannot pass the intestinal membrane intact. Alkaline phosphatase on the brush border strips the phosphate, the free pyridoxal is absorbed, and the cell re-phosphorylates it inside. This is why taking the phosphorylated form does not bypass the conversion step people often expect it to. The chemistry is settled and worth knowing before paying extra for the activated form.
Dietary riboflavin arrives mostly as FMN and FAD bound to protein. Brush border phosphatases release free riboflavin, which is what the transporter carries. The same logic applies as with phosphorylated B6. It is an absorption step, not an effect on riboflavin's downstream role.
Pyrophosphate blocks hydroxyapatite crystal growth. The bone isoform of alkaline phosphatase cleaves it, which permits calcium and phosphate to be incorporated into the matrix. This is why bone-specific alkaline phosphatase is measured as a bone turnover marker. A turnover marker reports remodelling activity and is not itself a measure of bone strength.
K2 activates osteocalcin, which binds calcium in bone matrix, while alkaline phosphatase clears the pyrophosphate brake on mineralisation. The two act at different points of the same remodelling process. Studies of K2 report movement in bone alkaline phosphatase alongside other markers. Marker movement is not the same as a change in fracture risk, and the two should not be reported as one thing.
Phytase strips phosphate from phytic acid in the acidic upper gut, freeing minerals that phytate would otherwise bind. Alkaline phosphatase works at alkaline pH further down and on different phosphate esters. Formulated together they cover a wider substrate and pH range than either does alone. The two are complementary rather than interchangeable.
Intestinal alkaline phosphatase has been studied for its role at the gut barrier, and zinc carnosine is used with barrier integrity in mind while also supplying the zinc that the enzyme requires. The overlap is mechanistic and the human data for the combination is not there. Read it as a formulation rationale, not a demonstrated pairing.
Removing a phosphate group from the lipid A portion of lipopolysaccharide markedly lowers its signalling activity at TLR4. That is one reason intestinal alkaline phosphatase is studied as a regulator of the gut interface with resident bacteria. Live organisms shift the composition of that bacterial load. The combined effect in people has not been measured.
Intestinal alkaline phosphatase expression is induced by dietary fat and sits on the same brush border where bile salt micelles deliver lipid. The functions are adjacent rather than dependent. No trial has tested the pair. It is offered as physiology, not a recommendation.
Nothing specific on file for Phosphatase. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 4 we read for Phosphatase. The full linked list is below.
7 sources behind our Phosphatase verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Read this carefully. These are 113 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Phosphatase is, not how risky it is. A report is not proof Phosphatase caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.